warning icon
Public Announcement Concerning a Proposed Health Care Project

Baystate Health intends to file a Notice of Determination of Need Application with the Mass. Dept. of Public Health with respect to a Proposed Project involving Trinity Health Of New England’s Mercy Medical Center.

Learn More

Hematology Oncology Scholarship

Scholarship is an important component to our Hematology Oncology Fellowship Program. Our fellows are encouraged to explore a wide range of research opportunities, including clinical research, quality improvement and review articles with mentorship from faculty members.

Below, we have a repository of a few publications and poster presentations in the last 3 years coming out from our fellows and faculty members.

Discover Our Division's Publications
  1. Bhardwaj PV, Tarantino P, Schlam I. Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions. Ther Adv Med Oncol. 2026 Mar 13;18:17588359261432056. doi: 10.1177/17588359261432056.
  2. Gould D, Walker R, Makari-Judson G, Seven M. The Experiences and Needs of Individuals with a Variant of Uncertain Significance on Genetic Tests for Hereditary Cancer Syndromes:A Grounded Theory Study. Semin Oncol Nurs. 2026 Feb 19:152148. doi: 10.1016/j.soncn.2026.152148. Epub ahead of print.
  3. Abdelsayed K, Najah Q, Mohamed AA, Amer BE, Eltanbedawi A, Abdelazeem B, Kunadi A, Brito D. Prognostic implications of factor VIII levels in African Americans: insights from a propensity-matched US-based multicenter retrospective analysis. J Thromb Thrombolysis. 2025 Oct;58(7):794-805. doi: 10.1007/s11239-025-03119-w. Epub 2025 May 29.
  4. Abushalha K, Ng A, Pulipati S, Bhardwaj P. Breast cancer screening for transgender individuals with breast cancer susceptibility genes. Transl Breast Cancer Res. 2025 Apr 27;6:16. doi: 10.21037/tbcr-24-68.
  5. Bhardwaj PV, Abdou Y. Managing pregnancy-associated breast cancer: A practical approach. Semin Perinatol. 2025 Mar;49(2):152037. doi: 10.1016/j.semperi.2025.152037.
  6. Yunes MJ. Radiation Therapy for Dupuytren Contracture. Pract Radiat Oncol. 2025 Jan 15:S1879-8500(24)00349-7. doi: 10.1016/j.prro.2024.11.010.
  7. Avelino ARM, Pulipati S, Jamouss K, Bhardwaj PV. Updates in Treatment of HER2-positive Metastatic Breast Cancer. Curr Treat Options Oncol. 2024 Nov 9. doi: 10.1007/s11864-024-01277-2.
  8. Bendapudi PK, Foy BH, Mueller SB, Liu J, Feingold LM, Burke KE, Cruz W, Chen MY, Lau ES, Goldberg RL, Tatake I, Wilkinson SC, Carney BJ, Stone JR, Park D, Avelino AR, Hassan S, Andrzejewski C, Ruby KN, Friedman KD, Brunker PAR, Leaf RK, Higgins J, Dzik WH, Stefely JA, Makar RS. Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2024 May 9;390(18):1690-1698. doi: 10.1056/NEJMoa2402567. PMID: 38718359; PMCID: PMC11128310.
  9. Bhardwaj PV, Gupta S, Elyash A, Teplinsky E. Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship. Curr Oncol Rep. 2024 Jan 2. doi: 10.1007/s11912-023-01489-z.
  10. Bhardwaj PV, Abdou Y. Navigating Treatment Pathways in Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: Optimizing Second-Line Endocrine and Targeted Therapies. J Clin Oncol. 2024 Sep 18:JCO2401295. doi: 10.1200/JCO-24-01295.
  11. Diaz FC, Hamparsumian A, Loh KP, Verduzco-Aguirre H, Abdallah M, Williams GR, Hsu T, Soto-Perez-de-Celis E, Elias R. Geriatric Oncology: A 5-Year Strategic Plan. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e100044. doi: 10.1200/EDBK_100044.
  12. Sharma N, Loscocco GG, Gangat N, Guglielmelli P, Pardanani A, Vannucchi AM, Alkhateeb HB, Tefferi A, Ho VT. When and how to transplant in myelofibrosis - recent trends. Leuk Lymphoma. 2024 Nov 14:1-19. doi: 10.1080/10428194.2024.2422835.
  13. Smart AC, Yunes MJ, Winkfield KM. Policy Priorities in Cancer Care for Transgender People. JAMA Oncol. 2024 Apr 18. doi: 10.1001/jamaoncol.2024.0451.
  14. Bhardwaj PV, Wang Y, Brunk E, Spanheimer PM, Abdou YG. Advances in the Management of Early-Stage Triple-Negative Breast Cancer. Int J Mol Sci. 2023 Aug 5;24(15):12478. doi: 10.3390/ijms241512478.
  15. Bhardwaj PV, Abdou YG. The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer. Oncologist. 2023 Aug 19:oyad233. doi: 10.1093/oncolo/oyad233.
  16. Bhardwaj PV, Clarke AC, Knee A, Gottlieb AS, Jobbins KA. Representation of Women Among Grand Rounds Speakers at an Academic Health System Early in the COVID-19 Pandemic. Cureus. 2023 Jun 29;15(6):e41150. doi: 10.7759/cureus.41150.
  17. Bhardwaj PV, Dulala R, Rajappa S, Loke C. Breast Cancer in India: Screening, Detection, and Management. Hematol Oncol Clin North Am. 2023 Jun 15:S0889-8588(23)00069-2. doi: 10.1016/j.hoc.2023.05.014.
  18. Bhardwaj PV, Mason H, Kaufman SA, Visintainer P, Makari-Judson G. Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center. Curr Oncol. 2023 May 8;30(5):4861-4870. doi: 10.3390/curroncol30050366.
  19. Schwartz GN, Kaufman PA, Giridhar KV, Marotti JD, Chamberlin MD, Arrick BA, Makari-Judson G, Goetz MP, Soucy SM, Kolling F, Demidenko E, Miller TW. Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer. Clin Cancer Res. 2023 May 15:CCR-23-0112. doi: 10.1158/1078-0432.CCR-23-0112.
  20. Sharma N, Liesveld JL. NPM 1 Mutations in AML-The Landscape in 2023. Cancers (Basel). 2023 Feb 12;15(4):1177. doi: 10.3390/cancers15041177.
  21. Sharma N, Wayant C, Neupane K, Lenka J, Berger K, Goodman AM, Booth CM, Prasad V, Mohyuddin GR. Quality of content reporting on two major oncology media websites: OncLive and Targeted Oncology. J Cancer Policy. 2023 Feb 9:100411. doi: 10.1016/j.jcpo.2023.100411.  

Discover Out Division's Conference Posters and Abstracts
  1. Kamelah Abushalha, Peter Silberstein. Clinicopathologic features and survival outcomes of stage IE pulmonary marginal zone lymphoma: A National Cancer Database (NCDB) analysis. Accepted for Abstract Publication at ASCO Annual Meeting 2026
  2. Andrew Ng, Sudeep Siddappa Malleshappa. The CNS exile: An AI-driven audit of active brain metastasis exclusions in modern NSCLC immunotherapy clinical trials. Accepted for Abstract Publication at ASCO Annual Meeting 2026
  3. Andrew Ng, Wilson C. Mertens, Sudeep Siddappa Malleshappa. Cumulative barriers to access: An AI-driven analysis of eligibility restrictions, clinical setting, and molecular gatekeeping in 509 interventional glioblastoma trials (2016-2025). Accepted for Abstract Publication at ASCO Annual Meeting 2026
  4. Dawood Hasan Syed, Saumil Parikh, Haiden Bin Khalid, Ghanshyambhai Savani, Sudeep K. Siddappa Malleshappa, Ahmad Hanif, Kathan Mehta. Comparative inpatient outcomes among FDA-approved chimeric antigen receptor T-cell products: An analysis of the 2023 National Inpatient Sample. Accepted for Abstract Publication at ASCO Annual Meeting 2026
  5. Anisha Karim, Yesenia Greeff, Rawad Elias, Eduardo Nunez. Likelihood of colorectal cancer screening by poor health status: A cross-sectional analysis of the Behavioral Risk Factor Surveillance System 2022. Accepted for Abstract Publication at ASCO Annual Meeting 2025
  6. Kamelah Abushalha, Abinesh Sekar, Peter Silberstein. Clinicopathological features and survival outcomes in patients with high microsatellite instability small intestine cancers: A National Cancer Database analysis. Accepted for Abstract Publication at ASCO Annual Meeting 2025
  7. Divya Solipuram, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa. Gender Disparity in Chimeric Antigen Receptor T-cell therapy utilization and outcomes in the United States. Accepted for poster presentation at ASCO Annual Meeting 2024
  8. Divya Solipuram, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa. Trends in the thrombotic complications of myeloproliferative neoplasms: A nationwide analysis. Accepted for poster presentation at ASCO Annual Meeting 2024
  9. Prarthna V. Bhardwaj, Sneha Nagesh Rao, Deepak Pasupula, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa. The impact of COVID-19 on national trends of hospitalization and outcomes for acute leukemias. Accepted for Abstract Publication at ASCO Annual Meeting 2023
  10. Prarthna V Bhardwaj, Lekha Yadukumar, Ishani Patel, Deepak Pasupula, Chandravathi Loke, Kathan Mehta, Sudeep Kumar Siddappa Malleshappa. Did COVID-19 impact national trends of hospitalization and outcomes for neutropenic fever in adults with cancer? Accepted for Abstract Publication at ASCO Annual Meeting 2023
  11. Maryam Naser, Prarthna V Bhardwaj, Fatima Zahid Warriach, Yamna Jadoon, Kush Gupta, Vida Rastegar, Chandravathi Loke, Sudeep Kumar Siddappa Malleshappa. Real-world effectiveness of prophylactic tixagevimab-cilgavimab monoclonal antibodies on incidence and severity of COVID-19 infection in patients with cancer. Accepted for Abstract Publication at ASCO Annual Meeting 2023. Also presented as an oral presentation through the medical student and resident interest group through ASCO
  12. Edison Tsui, Katherine Reeves, Isabella Caruso, Grace Makari-Judson. The impact of COVID-19 on anxiety among breast cancer survivors before, during and after the pandemic. Accepted for Abstract Publication at ASCO Annual Meeting 2023

Back to Top